Literature DB >> 3050180

Orthotopic liver transplantation for alcoholic cirrhosis.

T E Starzl1, D Van Thiel, A G Tzakis, S Iwatsuki, S Todo, J W Marsh, B Koneru, S Staschak, A Stieber, R D Gordon.   

Abstract

Fifteen patients with Laennec's cirrhosis underwent orthotopic liver transplantation between 1963 and the end of 1979. The first eight patients died perioperatively or within two months, but four of the next seven patients had long survival; three are still alive after 11 to 14 years. After the introduction of cyclosporine therapy, 41 more patients with alcoholic cirrhosis were treated with liver transplantation from 1980 to June 1987. The one-year survival is 73.2%, and, after one to three years, 28 (68%) of the recipients are living. Of the 35 patients in the combined old and new series who lived for six months or longer, only two returned to alcohol abuse. Social and vocational rehabilitation has been the rule in these recipients who were selected primarily because of urgency of need, because they or their families insisted on treatment, and because they and their families thereby committed themselves to long-standing programs of alcoholism care.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050180      PMCID: PMC3091380     

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.

Authors:  T E Starzl; C W Putnam; M Ishikawa; R Picache; B Husberg; C G Halgrimson; G Schroter; K A Porter
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

2.  Alcoholism and orthotopic liver transplantation.

Authors:  D K Flavin; R G Niven; J E Kelsey
Journal:  JAMA       Date:  1988-03-11       Impact factor: 56.272

3.  Equitable allocation of extrarenal organs: with special reference to the liver.

Authors:  T E Starzl; R D Gordon; A Tzakis; S Staschak; V Fioravanti; B Broznick; L Makowka; H T Bahnson
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

4.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

5.  License to plunder or to paint.

Authors:  G D Lundberg
Journal:  JAMA       Date:  1983-12-02       Impact factor: 56.272

6.  Liver transplantation.

Authors: 
Journal:  JAMA       Date:  1983-12-02       Impact factor: 56.272

Review 7.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

8.  The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy.

Authors:  T F O'Donnell; R M Gembarowicz; A D Callow; S G Pauker; J J Kelly; R A Deterling
Journal:  Surgery       Date:  1980-11       Impact factor: 3.982

9.  Liver transplantation with use of cyclosporin a and prednisone.

Authors:  T E Starzl; G B Klintmalm; K A Porter; S Iwatsuki; G P Schröter
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

10.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847

  10 in total
  33 in total

1.  Liver transplantation for alcoholic liver disease: a consideration of reasons for and against.

Authors:  D H Van Thiel; J S Gavaler; R E Tarter; V J Dindzans; R D Gordon; S Iwatsuki; L Makowka; S Todo; A Tzakis; T E Starzl
Journal:  Alcohol Clin Exp Res       Date:  1989-04       Impact factor: 3.455

2.  Liver transplantation under cyclosporine: a decade of experience.

Authors:  R D Gordon; S Todo; A G Tzakis; J J Fung; A Stieber; S M Staschak; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Liver transplantation--challenges for the future.

Authors:  E B Keeffe
Journal:  West J Med       Date:  1991-11

Review 4.  Alcoholic liver disease.

Authors:  A D Thomson; G L Bird; J B Saunders
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 5.  Surgical management of portal hypertension.

Authors:  J C Collins; I J Sarfeh
Journal:  West J Med       Date:  1995-06

6.  Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.

Authors:  F A Casavilla; J Rakela; S Kapur; W Irish; J McMichael; A J Demetris; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-11

Review 7.  Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.

Authors:  Diogo Telles-Correia; Inês Mega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 8.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Controversies in patient selection for liver transplantation.

Authors:  E B Keeffe; C O Esquivel
Journal:  West J Med       Date:  1993-11

10.  Lower relapse rates with good post-transplant outcome in alcoholic liver disease: Experience from a living donor liver transplant center.

Authors:  Sanjiv Saigal; Narendra Singh Choudhary; Sanjay Kumar Yadav; Neeraj Saraf; Naveen Kumar; Rahul Rai; Saurabh Mehrotra; Vipul Rastogi; Amit Rastogi; Sanjay Goja; Prashant Bhangui; Sumana K Ramachandra; Vikram Raut; Dheeraj Gautam; Arvinder Singh Soin
Journal:  Indian J Gastroenterol       Date:  2016-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.